In Singapore only a Healthcare Services Act licensee, or someone it authorises in writing, may advertise a licensable healthcare service, and the ad must be factual. The Healthcare Services (Advertisement) Regulations 2021 and the SMC Ethical Code and Ethical Guidelines ban testimonials, before/after images, laudatory claims and price promotions, even with patient consent. There is no pre-approval: MOH expects the licensee to prove every claim on request.
This is a working summary for marketing teams, not legal advice. Every rule below names the instrument it comes from so you can read the source rather than take our word for it, and so you can tell when something here has gone out of date.
Who regulates healthcare advertising in Singapore
- Healthcare Services Act 2020 (HCSA), s31: only a licensee or a person it authorises may advertise a licensable healthcare service
- Healthcare Services (Advertisement) Regulations 2021 (S 1033/2021), with the MOH FAQ on them (Oct 2023)
- Singapore Medical Council Ethical Code and Ethical Guidelines (2016 edition) and Handbook on Medical Ethics
- Health Products Act and Medicines (Advertisement and Sale) Act, enforced by the Health Sciences Authority
- Personal Data Protection Act 2012 and the PDPC Advisory Guidelines for the Healthcare Sector
More than one of these usually applies at once. A campaign can satisfy the advertising regulator and still breach the data-protection one, which is the failure mode that catches most practices: the creative gets reviewed and the tracking does not.
The rules that actually change what you can publish
- Only the HCSA licensee, or a person it has authorised in writing such as an employee or an agency, may advertise. The authorised person is liable alongside the licensee (HCSA s31).
- No patient testimonials or endorsements: a licensee may not reproduce any testimonial, endorsement or patient photo on its premises, website or social media, including re-sharing a patient's post, and consent does not change that (HCS (Advertisement) Regulations 2021, Reg 14). The SMC Ethical Code and Ethical Guidelines also bar doctors from asking or inducing patients to write testimonials.
- No before-and-after or after-only photos or videos in ads, even with disclaimers. They may be shown to a patient during a consultation (Reg 5).
- No laudatory words such as “best”, even if true, and no promises of results within a set time (Reg 5; MOH FAQ Annex A).
- No price promotions: no discounts, discounted packages, “as low as”, “free”, “complimentary”, giveaways or instalment figures without the total. Only the exact final price may be listed (Regs 5, 12, 15).
- Influencers and other non-licensees may not advertise licensable healthcare services. The maximum penalty is S$20,000, 12 months' imprisonment, or both (MOH, 9 Jan 2024).
- Online reviews may stand only if organic, unpaid, unsolicited and unmodified, and the licensee may not reproduce them. Offering anything of value for a review is barred (Reg 14).
- An ad is in scope if anyone in Singapore can access it, so a clinic's own website always is, even when it targets medical tourists (Reg 3).
- Prescription-only medicines may not be advertised to the public (Health Products Act). SMS, WhatsApp and other push messages need the recipient's prior written consent (Reg 6(4)), and the PDPA's consent, Do Not Call and transfer rules apply to patient data.
How Branding Pioneers handles it
- We publish for a Singapore licensee only after it appoints us in writing as its authorised person, and the clinician signs off every asset.
- No testimonial or review campaigns, review-for-reward schemes, before/after galleries, influencer promotion, discounts, packages or referral campaigns.
- Copy is checked against MOH's list of laudatory terms, and prices appear only as the exact final figure with no prefix.
- Every claim has a substantiation source on file, and a takedown register lets us correct or remove material as soon as it is required (Reg 17).
- Push messages go only to people who gave prior written consent, and patient data reaches our India team only under written PDPA transfer agreements.
Tracking deserves the same scrutiny as copy. Analytics, pixels and remarketing tags routinely collect more than a healthcare provider is permitted to share, and the default installation of most of them is not compliant in Singapore. Audit what your tags send before you audit your ad copy.
Before you run anything
- Can you substantiate every claim in the creative, today, from a document you can produce?
- Do you have written consent for every patient who appears, covering this specific use?
- Has the approval or licence this market requires been granted, and is its number on the creative where required?
- Does your tracking send anything that identifies a patient or their condition?
- Has someone qualified in Singapore reviewed the campaign, not just the marketing team?
If the answer to the last one is no, that is the gap worth closing first. We work inside these rules daily and will tell you when something you want to publish is not worth the exposure, but we are a marketing agency, and a regulated market deserves a qualified reviewer as well.
Not legal advice. A planning summary of published rules, last checked on 11 October 2026. Rules change, so confirm the current text with the regulator or local counsel before relying on it.
